I agree that this site is using cookies. You can find further informations here.
X
Hjorth‐Hansen, Henrik
121  results:
Search for persons X
?
1

Long‐term tolerability and efficacy after initial PegIFN‐α ..:

Flygt, Hjalmar ; Söderlund, Stina ; Stentoft, Jesper...
European Journal of Haematology.  107 (2021)  6 - p. 617-623 , 2021
Link: https://doi.org/10.1111/..
 
?
2

TKI safety:

Hjorth‐Hansen, Henrik
HemaSphere.  3 (2019)  S2 - p. 51-53 , 2019
Link: https://doi.org/10.1097/..
 
?
3

Imatinib and pegylated IFN‐α2b discontinuation in first‐lin..:

Koskenvesa, Perttu ; Kreutzman, Anna ; Rohon, Peter...
European Journal of Haematology.  92 (2014)  5 - p. 413-420 , 2014
Link: https://doi.org/10.1111/..
 
?
4

Dasatinib induces fast and deep responses in newly diagnose..:

Hjorth‐Hansen, Henrik ; Stenke, Leif ; Söderlund, Stina...
European Journal of Haematology.  94 (2014)  3 - p. 243-250 , 2014
Link: https://doi.org/10.1111/..
 
?
5

Abnormal adipokine levels and leptin‐induced changes in gen..:

Reseland, Janne E. ; Reppe, Sjur ; Olstad, Ole K....
European Journal of Haematology.  83 (2009)  5 - p. 460-470 , 2009
Link: https://doi.org/10.1111/..
 
?
6

Expression of urokinase plasminogen activator and the uroki..:

Hjertner, Öyvind ; Qvigstad, Gunnar ; Hjorth‐Hansen, Henrik...
British Journal of Haematology.  109 (2000)  4 - p. 815-822 , 2000
Link: https://doi.org/10.1046/..
 
?
7

Interleukin‐15 blocks apoptosis and induces proliferation o..:

Hjorth‐Hansen, Henrik ; Waage, Anders ; Börset, Magne
British Journal of Haematology.  106 (1999)  1 - p. 28-34 , 1999
Link: https://doi.org/10.1046/..
 
?
8

Apoptosis, proliferation and NF‐κB activation induced by ag..:

Børset, Magne ; Hjorth‐Hansen, Henrik ; Johnsen, Ann‐Charlotte...
European Journal of Haematology.  63 (1999)  5 - p. 345-353 , 1999
Link: https://doi.org/10.1111/..
 
?
9

Hepatocyte growth factor in serum after injection of unfrac..:

Seidel, Carina ; Hjorth‐Hansen, Henrik ; Bendz, BjØrn...
British Journal of Haematology.  105 (1999)  3 - p. 641-647 , 1999
Link: https://doi.org/10.1046/..
 
?
10

Correction: Treatment-free remission after a second TKI dis..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia.  38 (2024)  4 - p. 925-925 , 2024
Link: https://doi.org/10.1038/..
 
?
11

Treatment-free remission after a second TKI discontinuation..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia.  38 (2024)  4 - p. 781-787 , 2024
Link: https://doi.org/10.1038/..
 
?
12

The SNP rs460089 in the gene promoter of the drug transport..:

Machova Polakova, Katerina ; Albeer, Ali ; Polivkova, Vaclava...
Leukemia.  38 (2023)  2 - p. 318-325 , 2023
Link: https://doi.org/10.1038/..
 
?
13

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRON..:

Efficace, Fabio ; Mahon, Francois-Xavier ; Richter, Johan...
HemaSphere.  7 (2023)  S3 - p. e0972454 , 2023
Link: https://doi.org/10.1097/..
 
?
14

Switching from imatinib to nilotinib plus pegylated interfe..:

Geelen, Inge G.P. ; Gullaksen, Stein-Erik ; Ilander, Mette M....
Annals of Hematology.  102 (2023)  6 - p. 1395-1408 , 2023
Link: https://doi.org/10.1007/..
 
?
15

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONS..:

Pfirrmann, Markus ; Mahon, Francois-Xavier ; Dulucq, Stéphanie...
HemaSphere.  7 (2023)  S3 - p. e230884b , 2023
Link: https://doi.org/10.1097/..
 
1-15